By Ruchika Sharma
Copyright medicaldialogues
Mumbai: Lupin has announced the retirement of Rajendra Chunodkar, President – Manufacturing Operations and a member of the Senior Management of the Company.During his tenure, Rajendra played a pivotal role in leading the company’s manufacturing operations in India, apart from corporate functions like EHS, Technology Transfer/Process Development, Projects and the Operational Excellence function.Rajendra has a degree in chemical engineering from the Institute of Chemical Technology, Mumbai and a management degree from the Indian School of Business, Hyderabad.Lupin Limited is a global pharmaceutical company headquartered in Mumbai, India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. The company has a strong position in India and the U.S. across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women’s health. Lupin has 15 state-of-the-art manufacturing sites and 7 research centers globally.
